compared the immune response generated by pDCs vs. cDCs in a DC-based vaccine strategy in a mouse glioma model; the results indicated that cDCs were more effective than pDCs in generating an anti-glioma Th-1 immune response (149). The gene discussed is NELFCD; the disease is central nervous system cancer.